EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 43 filers reported holding EVELO BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $44,000 | -55.6% | 12,930 | -20.9% | 0.00% | – |
| Q4 2021 | $99,000 | -13.9% | 16,344 | 0.0% | 0.00% | – |
| Q3 2021 | $115,000 | -80.0% | 16,344 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $576,000 | +54.8% | 41,923 | +20.7% | 0.00% | – |
| Q1 2021 | $372,000 | +1.6% | 34,735 | +14.8% | 0.00% | -100.0% |
| Q4 2020 | $366,000 | +218.3% | 30,268 | +38.7% | 0.00% | – |
| Q3 2020 | $115,000 | +7.5% | 21,824 | 0.0% | 0.00% | – |
| Q2 2020 | $107,000 | +30.5% | 21,824 | 0.0% | 0.00% | – |
| Q1 2020 | $82,000 | -6.8% | 21,824 | +1.1% | 0.00% | – |
| Q4 2019 | $88,000 | -33.3% | 21,579 | 0.0% | 0.00% | – |
| Q3 2019 | $132,000 | -32.0% | 21,579 | 0.0% | 0.00% | – |
| Q2 2019 | $194,000 | +12.1% | 21,579 | 0.0% | 0.00% | – |
| Q1 2019 | $173,000 | -38.4% | 21,579 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $281,000 | +181.0% | 21,579 | +163.0% | 0.00% | – |
| Q3 2018 | $100,000 | +3.1% | 8,206 | 0.0% | 0.00% | – |
| Q2 2018 | $97,000 | – | 8,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
| Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
| DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
| ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
| Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
| CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |